Skip to main content
Tevogen Bio Holdings Inc. logo

Tevogen Bio Holdings Inc. — Investor Relations & Filings

Ticker · TVGN ISIN · US88165K1016 US Professional, scientific and technical activities
Open in API
Filings indexed 269 across all filing types
Latest filing 2021-10-28 Capital/Financing Update
Country US United States of America
Listing US TVGN

About Tevogen Bio Holdings Inc.

https://tevogen.com/

Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company developing off-the-shelf, precision T cell therapies. The company utilizes its proprietary ExacTcell™ technology platform to harness the therapeutic potential of CD8+ cytotoxic T lymphocytes (CTLs), a key component of the natural immune system. This platform is designed to create treatments that specifically target antigens present only on diseased cells, thereby preserving healthy tissue and enhancing safety through the use of naturally occurring T cell receptors. The company's development pipeline addresses significant unmet medical needs across multiple therapeutic areas, including oncology, virology, and neurology, with a stated goal of providing affordable and accessible personalized therapies to large patient populations.

Recent filings

Filing Released Lang Actions
S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 4 to a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It includes detailed information about the securities being registered, underwriting agreements, indemnification of directors and officers, recent sales of unregistered securities, and exhibits related to the registration. The Form S-1 is a registration statement used for initial public offerings or other securities offerings, which is a capital raising activity. The document is not a financial report, earnings release, or management discussion but rather a regulatory filing related to capital markets and securities registration. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, consistent with a capital raising filing rather than a brief announcement or a report publication announcement.
2021-10-28 English
Regulatory Filings 2021
Regulatory Filings
2021-10-28 English
S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 3 to a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It includes detailed information about the securities being registered, underwriting agreements, indemnification of directors and officers, recent sales of unregistered securities, and exhibits related to the registration. The Form S-1 is a registration statement used for initial public offerings or other securities offerings, which is a capital raising activity. This document is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to capital markets and securities registration. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication announcement, but a substantive filing related to capital raising.
2021-10-27 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter from Semper Paratus Acquisition Corporation to the SEC responding to comments on an Amendment No. 1 to a Registration Statement on Form S-1. It discusses legal opinions, warrant agreements, and revisions to the Registration Statement. The document is a correspondence related to regulatory review and amendments to a registration filing, not the registration statement itself or a financial report. It is a regulatory filing responding to SEC comments, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous regulatory correspondence and compliance documents.
2021-10-26 English
S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 2 to a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It includes detailed information about the securities being registered, underwriting agreements, indemnification of directors and officers, recent sales of unregistered securities, and exhibits related to the registration. The Form S-1 is a registration statement used for initial public offerings or other securities offerings, which is a capital raising document. This is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to capital markets and securities registration. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed registration information, not just an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing fallback. Confidence is high due to the clear identification of the form and its purpose.
2021-10-26 English
Regulatory Filings 2021
Regulatory Filings
2021-10-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.